Solutions...

Pricing & Access
Strategies

Optimal pricing strategies for development decisions and market access.

Read more

Conjoint
Research

Delivering conjoint that can handle the intricacies of the pharma market.

Read more

Forecasting
Software

Allowing leading pharma companies to build evidence-based forecasts fast and easily.

Read more

Launch Sequence
Simulators

Get your country launch sequence right. Capture full value in the face of international reference pricing.

Read more

Training
Courses

Industry-leading pricing-for-market-access and forecasting training.

Read more

White papers

See head-to-head validation and evidence for why Inpharmation’s solutions are best placed to provide you with the most reliable insights

View

Making conjoint fit for pharma: Increase forecast accuracy with share drivers

Conjoint studies frequently assume that product profile is the dominant driver of market share. However, product profile is often not the dominant driver and rarely is it the sole driver…

Download White paper

Making conjoint fit for pharma: Transform your preference shares

So far in this series of papers on making conjoint fit for pharma, we have explored how you can increase the reliability of responses and decrease the required sample size…

Download White paper

Making conjoint fit for pharma: Shrink your sample size requirements

In the previous paper, we discussed why traditional conjoint approaches overburden respondents in pharma market research – and how overburdened respondents give unreliable results. In this paper, we explore the…

Download White paper

Making conjoint fit for pharma: Have mercy on your respondents

Conjoint is a wonderful idea for demand market research. By asking a sample of respondents a series of questions, you get an “X-ray” into their minds. You can quantify how…

Download White paper

Going beyond small-sample payer interviews: Reliable and quantitative value pricing research

Speaking to just a handful of payers risks your pricing strategy suffering from unreliable, wide-ranging price responses. Pricing strategies rely on quantitative metrics, and quantitative metrics must be powered with…

Download White paper

How best to forecast the uptake of new pharmaceuticals: The Bass model

Creating a forecast for a new pharmaceutical is daunting but exciting. The forecast is likely to be driven by just a few key assumptions: the treatable patient population, the peak…

Download White paper

How best to forecast the uptake of new pharmaceuticals: First-in-class products

Creating an uptake forecast for a first-in-class product is fraught with uncertainty. So far in this series of papers on uptake, we have covered how the Bass uptake model distils…

Download White paper

How best to forecast the uptake of new pharmaceuticals: Include the competition

Forecasting the uptake of competing products is complex and requires substantial Excel skills. The previously covered Bass model is great for forecasting individual product uptake, but what about when you…

Download White paper

What if the conjoint survey you need has already been done?

Conjoint survey research can deliver fantastic insights. It can provide you with product preferences which you can use to model how any number of current and future drugs compete for…

Download White paper

Looking for case studies?

Click below to discover our clients’ success stories.

We tailor our services to your exact requirements

Get in touch with us and arrange a meeting